XML 18 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Accumulated other comprehensive income (loss)
Beginning of period (in shares) at Sep. 30, 2023   27,466,000        
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)   190,000        
Treasury shares purchased (in shares)   (371,000)        
End of period (in shares) at Jun. 29, 2024   27,285,000        
Beginning of period at Sep. 30, 2023 $ 1,214,382 $ 543 $ 661,270 $ (1,134,429) $ 1,711,328 $ (24,330)
Exercise of stock options and vesting of other share-based awards   2        
Share-based compensation expense     19,759      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (10,830)      
Treasury shares purchased       (36,145)    
Net income 70,594       70,594  
Other comprehensive income (loss) 8,598         8,598
End of period at Jun. 29, 2024 1,266,360 $ 545 670,199 (1,170,574) 1,781,922 (15,732)
Beginning of period (in shares) at Mar. 30, 2024   27,470,000        
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)   0        
Treasury shares purchased (in shares)   (185,000)        
End of period (in shares) at Jun. 29, 2024   27,285,000        
Beginning of period at Mar. 30, 2024 1,259,762 $ 545 663,130 (1,151,997) 1,756,782 (8,698)
Exercise of stock options and vesting of other share-based awards   0        
Share-based compensation expense     7,074      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (5)      
Treasury shares purchased       (18,577)    
Net income 25,140       25,140  
Other comprehensive income (loss) (7,034)         (7,034)
End of period at Jun. 29, 2024 $ 1,266,360 $ 545 670,199 (1,170,574) 1,781,922 (15,732)
Beginning of period (in shares) at Sep. 28, 2024 27,122,000 27,122,000        
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)   177,000        
Treasury shares purchased (in shares)   (314,000)        
End of period (in shares) at Jun. 28, 2025 26,985,000 26,985,000        
Beginning of period at Sep. 28, 2024 $ 1,324,825 $ 545 680,638 (1,190,115) 1,823,143 10,614
Exercise of stock options and vesting of other share-based awards   2        
Share-based compensation expense     22,466      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (15,102)      
Treasury shares purchased       (43,807)    
Net income 121,456       121,456  
Other comprehensive income (loss) 9,245         9,245
End of period at Jun. 28, 2025 $ 1,419,085 $ 547 688,002 (1,233,922) 1,944,599 19,859
Beginning of period (in shares) at Mar. 29, 2025   27,122,000        
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)   6,000        
Treasury shares purchased (in shares)   (143,000)        
End of period (in shares) at Jun. 28, 2025 26,985,000 26,985,000        
Beginning of period at Mar. 29, 2025 $ 1,351,675 $ 547 680,880 (1,215,481) 1,899,483 (13,754)
Exercise of stock options and vesting of other share-based awards   0        
Share-based compensation expense     7,695      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (573)      
Treasury shares purchased       (18,441)    
Net income 45,116       45,116  
Other comprehensive income (loss) 33,613         33,613
End of period at Jun. 28, 2025 $ 1,419,085 $ 547 $ 688,002 $ (1,233,922) $ 1,944,599 $ 19,859